MASH Redefined: Insights from the EASL Congress 2025

THE EUROPEAN Association for the Study of the Liver (EASL) Congress 2025, Amsterdam, the Netherlands, placed patients and the public at the heart of its agenda, emphasising the importance of liver health through early detection, prevention, and improved access to emerging treatments.The meeting served as a strategic inflection point to assess real-world data and address the implications of the newly adopted steatotic liver disease (SLD) nomenclature.This feature distils the key emerging themes from the congress, spanning public engagement, policy change, implications of the new SLD framework, and clinical data from repurposed drugs to target a wider patient population.